Merck (MRK) Cash from Investing Activities (2009 - 2026)

Merck (MRK) has reported Cash from Investing Activities for 18 consecutive years, with -$5.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 627.53% year-over-year to -$5.6 billion in Q2 2026; TTM through Jun 2026 was -$27.3 billion, a 261.73% decrease from a year earlier, with the FY2025 full-year figure at -$13.7 billion, down 77.67% from the prior year.
• Cash from Investing Activities was -$5.6 billion for Q2 2026 at Merck, up from -$10.2 billion in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $53.0 million in Q4 2023 and troughed at -$11.4 billion in Q2 2023.
• A 5-year average of -$3.1 billion and a median of -$1.4 billion in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 103.03% in 2023 and slumped 2824.53% in 2024, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$1.7 billion in 2022, then jumped by 103.03% to $53.0 million in 2023, then tumbled by 2824.53% to -$1.4 billion in 2024, then slumped by 675.69% to -$11.2 billion in 2025, then surged by 49.99% to -$5.6 billion in 2026.
• The last three Cash from Investing Activities figures came in at -$5.6 billion (Q2 2026), -$10.2 billion (Q1 2026), and -$11.2 billion (Q4 2025), per Business Quant data.